Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Chronic Obstructive Pulmonary Disease (COPD) Research, and Respiratory and Cough-Related Research.
Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity
Clinical importance of patient-reported outcome measures in severe asthma: results from U-BIOPRED
The role of inflammation in anxiety and depression in the European U-BIOPRED asthma cohorts
Allergen provocation tests in respiratory research: building on 50 years of experience
Clinical and transcriptomic features of persistent exacerbation‐prone severe asthma in U‐BIOPRED cohort
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study
Correlation-Based Deconvolution (CorrDec) To Generate High-Quality MS2 Spectra from Data-Independent Acquisition in Multisample Studies
Bronchodilator reversibility in asthma and COPD: findings from three large population studies
Characteristics and treatment regimens across ERS SHARP severe asthma registries
Contribution of airway eosinophils in airway wall remodeling in asthma: Role of <i><scp>MMP</scp>‐10</i> and <i><scp>MET</scp></i>
Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation
Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis
Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort
Serum periostin relates to type‐2 inflammation and lung function in asthma: Data from the large population‐based cohort Swedish <scp>GA</scp>(2)<scp>LEN</scp>
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED
Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69−CD56dim cells
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses
Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD
Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study
Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease
Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease
Integrated care pathways for airway diseases (AIRWAYS-ICPs)